Monitoring Allogeneic CAR-T Cells Using Flow Cytometry

Agnieszka Jozwik, Alan Dunlop, Katy Sanchez, Reuben Benjamin

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

Chimeric antigen receptor T cell (CAR-T) therapies have now entered mainstream clinical practice with two approved autologous CAR-T products targeting CD19 and numerous other products in early and late phase clinical trials. This has led to a demand for highly sensitive, specific, and easily reproducible methods to monitor CAR-T cells in patients. Here we describe a flow cytometry based protocol for detection of allogeneic CAR-T cells and for monitoring their phenotype and numbers in blood and bone marrow of patients following CAR-T treatment.

Original languageEnglish
Pages (from-to)293-308
Number of pages16
JournalMethods in molecular biology (Clifton, N.J.)
Volume2097
DOIs
Publication statusPublished - 1 Jan 2020

Keywords

  • Allogeneic
  • Cancer
  • CAR-T cells
  • Flow cytometry
  • Gene knockout
  • Immunotherapy

Fingerprint

Dive into the research topics of 'Monitoring Allogeneic CAR-T Cells Using Flow Cytometry'. Together they form a unique fingerprint.

Cite this